32 completed, 14 recruiting, 9 unknown, 4 active not recruiting. 67 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 67 | Completed 32, Recruiting 14, Unknown 9, Active not recruiting 4, Not yet recruiting 3, Terminated 3, Withdrawn 2 |
Follow Hematologic Malignancy: new trials by email Literature Review of Hematologic Malignancy trials Research Report on Hematologic Malignancy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Symptom Monitoring and Management Intervention After CAR-T WAYPOINT - Chimeric Antigen Receptor T-cell Therapy, Hematologic Malignancy | Not applicable | Not yet recruiting | Massachusetts General Hospital | 65 | 2027-03-01 | 2026-10-23 |
| Study to Characterize Mismatched to Fully HLA-Matched Ossium HPC, Marrow and Living Donor Transplantation in Patients With Hematologic Malignancies Ossium HPC, Marrow, Standard of care living donor - Haplo Related, Standard of care living donor - Mismatched Unrelated - Hematologic Malignancy, Acute Leukemia | Not applicable | Not yet recruiting | Ossium Health, Inc. | 300 | 2026-12-01 | 2026-09-10 |
| Assessing DCog Short for Neurotoxicity in CAR-T DCog Short - Neurotoxicity, Neurotoxicity Syndromes | Not applicable | Recruiting | Beth Israel Deaconess Medical Center | 40 | 2026-04-13 | 2026-10-08 |
| Expressive Writing Program Among Young Adults With Blood Cancer Expressive Writing Workshop - Hematologic Malignancy | Not applicable | Active not recruiting | Blood Cancer United | 100 | 2026-02-01 | 2026-08-13 |
| ONC-MM-2407: The Effect of Virtual Reality Headsets on Pain and Anxiety in the Peri and Post Bone Marrow Biopsy Period Standard of Care, Virtual Reality intervention - Hematologic Malignancy | Not applicable | Recruiting | Wake Forest University Health Sciences | 160 | 2026-01-23 | 2026-07-23 |
| Mindfulness Intervention for Sleep Disturbance and Symptom Management in Hematologic Cancer Patients During and After Inpatient Treatment Nite2Day+ - Hematologic Malignancy | Not applicable | Recruiting | Duke University | 60 | 2026-01-14 | 2026-07-08 |
| Feasibility and Acceptability of Primary Palliative Care Intervention in Patients Undergoing Hematopoietic Stem Cell Transplantation Primary palliative care - Hematopoietic Cell Transplant, Hematologic Malignancy | Not applicable | Recruiting | Massachusetts General Hospital | 40 | 2026-01-05 | 2026-04-24 |
| HEME Home Transfusion Program HEME-Hospice Program - Leukemia, Myeloma | Not applicable | Recruiting | Dana-Farber Cancer Institute | 700 | 2025-09-10 | 2026-10-28 |
| Home Blood Transfusions Home Blood Transfusion - Hematologic Malignancy, Myelodysplastic Syndromes | Not applicable | Recruiting | Thomas Jefferson University | 30 | 2025-06-03 | 2025-12-16 |
| Implementation of an Oral Chemotherapy Adherence Intervention Multilevel Adherence Intervention - Solid Tumor, Hematologic Malignancy | Not applicable | Recruiting | UNC Lineberger Comprehensive Cancer Center | 160 | 2025-05-28 | 2026-07-08 |
| TCRαβ/CD19 Depletion of Stem Cell Grafts for Transplant CliniMACS® device - Graft Vs Host Disease, Graft-versus-host-disease | Not applicable | Withdrawn | Neena Kapoor, M.D. | 2025-05-27 | 2025-07-14 | |
| Mosaic Trial for Stem Cell Transplant Recipients Intervention website, Enhanced Usual Care (Control) Website - Hematologic Malignancy, Stem Cell Transplant | Not applicable | Recruiting | Northwestern University | 356 | 2025-04-28 | 2026-10-30 |
| Comparing Diosmin-Hesperidin and Loratadine to Prevent Bone Pain From G-CSF in Patients With Blood Cancers Loratadine, Diosmin-Hesperidin, Loratadine + Diosmin-Hesperidin - Hematologic Malignancy, Neutropenia | Not applicable | Recruiting | Alexandria University | 88 | 2025-03-01 | 2026-06-24 |
| A Study of the Effect of Laughter Therapy on the Mental Health and Quality of Survival of Hematopoietic Stem Cell Transplant Patients laughter therapy intervention - Hematologic Malignancy, Hematopoietic Stem Cell Transplant | Not applicable | Not yet recruiting | Institute of Hematology & Blood Diseases Hospital, China | 98 | 2025-01-31 | 2025-01-24 |
| BMT-CARE: Psychosocial Intervention for Transplant Caregivers BMT-CARE, Usual Care - Bone Marrow Transplant Complications, Hematologic Malignancy | Not applicable | Recruiting | Massachusetts General Hospital | 800 | 2025-01-10 | 2025-10-15 |
| Let's Get REAL: Family Health Communication Tool in Pediatric Stem Cell Transplant and Cellular Therapy Let's Get REAL - Hematologic Malignancy, Solid Tumor | Not applicable | Recruiting | Washington University School of Medicine | 60 | 2024-11-26 | 2026-06-04 |
| Home Transfusion for HEME Home Transfusion Program Components - Hematologic Malignancy | Not applicable | Completed | Dana-Farber Cancer Institute | 10 | 2024-10-18 | 2025-09-25 |
| VitalTraq for the Detection of CRS TempTraq, VitalTraq - Hematologic Malignancy | Not applicable | Completed | Duke University | 32 | 2024-10-13 | 2026-07-15 |
| Improving Quality of Life in Older Patients With Frailty and Hematological Cancer Through Geriatric Assessment Comprehensive geriatric assessment (CGA) and treatment - Hematologic Malignancy, Treatment Adherence | Not applicable | Unknown | Odense University Hospital | 152 | 2024-04-02 | 2024-04-18 |
| A Positive Psychology Based Intervention (PATH-C) for Caregivers of HSCT Survivors PATH-C - Hematologic Malignancy, Caregiver | Not applicable | Active not recruiting | Brigham and Women's Hospital | 80 | 2024-01-01 | 2026-02-06 |
Showing 20 of 67. Sign in to see all of them.
Hematologic Neoplasms (67) · Lymphoma (9) · Neoplasms (8) · Leukemia (7) · Myelodysplastic Syndromes (5) · Hematologic Diseases (4) · Leukemia, Myeloid, Acute (4) · Fatigue (3) · Frailty (3) · Multiple Myeloma (3) · Neoplasms, Plasma Cell (3) · Anemia, Sickle Cell (2) · Anxiety Disorders (2) · Breast Neoplasms (2) · Graft vs Host Disease (2)
Hemic and Lymphatic Diseases (67) · Neoplasms by Site (66) · Hematologic Diseases (63) · Neoplasms (59) · Immune System Diseases (13) · Neoplasms by Histologic Type (12) · Pathological Conditions, Signs and Symptoms (12) · Immunoproliferative Disorders (11) · Lymphatic Diseases (11) · Lymphoproliferative Disorders (11) · Signs and Symptoms (8) · Bone Marrow Diseases (7) · Pathologic Processes (6) · Behavior (4) · Leukemia, Myeloid (4)
Exercise (2) · Amino Acids (1) · Blood Cell Count (1) · Control Groups (1) · Cyclophosphamide (1) · Death Domain (1) · Filgrastim (1) · Geriatric Assessment (1) · Glucose (1) · Haemophilus influenza type b polysaccharide vaccine-tetanus toxin conjugate (1) · High-Intensity Interval Training (1) · Imagery, Psychotherapy (1) · Influenza Vaccines (1) · Loratadine (1) · Melphalan (1)
Massachusetts General Hospital (11) · Duke University (5) · Brigham and Women's Hospital (4) · Dana-Farber Cancer Institute (4) · Masonic Cancer Center, University of Minnesota (2) · Acibadem University (1) · Adam Olszewski (1) · Alberta Health services (1) · Alexandria University (1) · Aperture Medical Technology, LLC (1) · Baskent University (1) · Beth Israel Deaconess Medical Center (1) · Blood Cancer United (1) · Brno University Hospital (1) · Cedars-Sinai Medical Center (1)
United States (44) · Turkey (Türkiye) (3) · Canada (2) · Denmark (2) · France (2) · Spain (2) · China (1) · Czechia (1) · Egypt (1) · Ethiopia (1) · Israel (1) · Italy (1) · Malaysia (1) · Russia (1) · United Kingdom (1)
Areej El-Jawahri, MD (3) · Hermioni Amonoo, MD, MPP, MPH (3) · Chenyu Lin, MD (2) · Patrick C Johnson, MD (2) · Adam Binder, MD (1) · Alessandro Passardi, MD (1) · Alexander Kulagin, Professor (1) · Ant Uzay, MD (1) · Anthony Sung, MD (1) · Arash Asher, M.D. (1) · Ashley Nelson, PhD (1) · Benyam Muluneh, PharmD (1) · Brian Shaffer, MD (1) · Celina Shirazipour, PhD (1)
PMID 26822328, PMID 34649555, PMID 35017254, PMID 35397575, PMID 35436209, PMID 36027848, PMID 36163030, PMID 37328178, PMID 37442349, PMID 38597262, PMID 39080734, PMID 39606939, PMID 39828642, PMID 39886490, PMID 39954038, PMID 40056908, PMID 40204300
K08CA251654 (1), K08CA279500 (1), K08CA283026 (1), K12CA167540 (1), P30CA012197 (1), R01CA292116 (1), R03CA270671 (1), R37CA289639 (1), R41CA314618 (1), R44CA236557 (1)